NEWS >>
Date
Title
1
2
3
4
Page size:
select
10
20
25
50
89
items in
4
pages
1/15/2013
U.S. FDA Approves ELIQUIS® (apixaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation
11/26/2012
Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC
11/26/2012
Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia
10/31/2012
We are pleased to announce that on July 31, 2012, the Kedrion Group finalized the acquisition of the RhoGAM® line of products from Ortho-Clinical Diagnostics, Inc. (OCD).
9/24/2012
Azerbaijan earth quake
6/29/2012
Astellas Pharma receives FDA approval for Myrbetriq to treat overactive bladder
6/20/2012
Final results from MSD’s VICTRELIS plus PEGINTRON Phase III trial on HCV treatment-related anemia
2/25/2012
Turning Interdisciplinary Brain Tumor Science into Survival; Report from the Neuro-Oncology Scientific Club Opening Session, NOSC 2012 -19 January- Tehran, IR Iran
2/18/2012
Quit-smoking drug Chantix effective in cocaine and alcohol addiction
2/2/2012
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
1/1/2012
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults
11/5/2011
No link between Chantix and mental health problems says FDA
10/22/2011
Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA
8/22/2011
Scientific Leaders Meeting, Protease Inhibitors in Hepatitis C, Local consensus from Iran.
7/12/2011
Former smokers with lung cancer can benefit from celecoxib treatment
7/5/2011
Obstetricians/gynecologists rank Pfizer as No. 1 pharmaceutical company: SDI
5/25/2011
FDA approves Victrelis for Hepatitis C
5/6/2011
Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension
5/6/2011
Flu vaccination lowers kidney transplant recipients' risk of organ loss and death
4/13/2011
FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors
2/27/2011
Astellas' Protopic receives Health Canada approval for prevention of eczema flares
12/30/2010
Centocor files REMICADE for ulcerative colitis in pediatric patients
12/21/2010
Simponi (golimumab) penetrates first line biologic position in RA
12/9/2010
Australia’s federal government will subsidize the cost of Champix (varenicline) to help smokers quit.
12/2/2010
European Commission approves Pfizer's SUTENT for pancreatic neuroendocrine tumors
Home
|
About us
|
Our Products
|
Information Center
|
Carrer
|
News
|
Contact Us
|
HR Portal
|
Check E-mail
Copyright © 2008 BEHESTAN DAROU (P.J.S)
